Home

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Next revisionBoth sides next revision
home:diseases:cardiovascular [12.26.2018] – [Cardiovascular diseases] sallieqhome:diseases:cardiovascular [08.01.2019] – [More information] sallieq
Line 1: Line 1:
  
  
-====== Cardiovascular diseases ======+====== Cardiovascular diseases ======  
  
-<relatedarticle> [[home:symptoms:cardiac|Managing cardiac symptoms]]</article>+<relatedarticles> [[home:symptoms:cardiac|Managing cardiac symptoms]],  [[home:food:aim_health:aging|Health maintenance with Olmesartan]] </article>
  
 Heart disease or cardiovascular diseases is the class of diseases that involve the heart or blood vessels (arteries and veins). While the term technically refers to any disease that affects the cardiovascular system, it is usually used to refer to those related to arteriosclerosis (hardening of the arteries).  Heart disease or cardiovascular diseases is the class of diseases that involve the heart or blood vessels (arteries and veins). While the term technically refers to any disease that affects the cardiovascular system, it is usually used to refer to those related to arteriosclerosis (hardening of the arteries). 
Line 251: Line 251:
 //**Jen Hicks**, MarshallProtocol.com//</blockquote> //**Jen Hicks**, MarshallProtocol.com//</blockquote>
 ===== More information ===== ===== More information =====
 +
 +Hyperuricaemia was associated with an unfavourable cardiovascular risk profile in HF patients. Treatment with low doses of allopurinol did not improve the prognosis of HF patients.  (({{pubmed>long:    31119751}}))
 +
 +Increased risks per 10 000 person-years found in estrogen plus progestin therapy for 16608 healthy postmenopausal women (studied over 5 years) were 7 more CHD events, 8 more strokes, 8 more PEs, and 8 more invasive breast cancers. (({{pubmed>long:12117397}}))
  
   * [[http://www.medicalnewstoday.com/articles/91894.php|Olmetec Is First Angiotensin Receptor Blocker (ARB) To Suggest Atherosclerosis Regression (in Hypertensives With Cardiovascular Risk)]]   * [[http://www.medicalnewstoday.com/articles/91894.php|Olmetec Is First Angiotensin Receptor Blocker (ARB) To Suggest Atherosclerosis Regression (in Hypertensives With Cardiovascular Risk)]]
home/diseases/cardiovascular.txt · Last modified: 09.14.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.